mk-2866 MK2866 Ostarine CAS: 841205-47-8

CAS NO: 841205-47-8
mk-2866 MK2866 Ostarine
MK2866 is ((2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide).

Molecular formula and formula weight:

The molecular formula of MK2866 is C19H18F3N3O6 and its formula weight is 441.36
Description Review
Description

MK2866, also known as Ostarine, is a selective androgen receptor modulator (SARM) that is used for the treatment of muscle wasting and osteoporosis. It is also used by athletes and bodybuilders as a performance enhancing drug due to its anabolic properties.

Top Searched Keywords on Google and Synonyms on Google:

Some of the top searched keywords on Google for MK2866 include “Ostarine”, “MK2866 dosage”, “MK2866 review”, “MK2866 benefits”, “MK2866 side effects”, and “MK2866 results”. Synonyms for MK2866 include GTx-024, Enobosarm, and S-22.

Health benefits:

MK2866 has been studied for its potential benefits in treating muscle wasting and osteoporosis. It has also been shown to have a positive effect on bone density and overall bone health. Additionally, MK2866 has shown potential for increasing lean muscle mass and improving athletic performance.

Potential Effects:

MK2866 has anabolic effects on muscle tissue, which means it promotes muscle growth and helps to maintain muscle mass. It also has anti-catabolic effects, which means it helps to prevent muscle breakdown. MK2866 has been shown to increase muscle strength and improve muscle endurance, which can be beneficial for athletes and bodybuilders.

Mechanisms:

MK2866 works by binding to androgen receptors in the body, which are responsible for regulating muscle growth and bone density. It selectively targets these receptors in muscle and bone tissue, which means it has minimal side effects compared to traditional anabolic steroids. MK2866 promotes the synthesis of proteins that are involved in muscle growth and repair, which leads to an increase in lean muscle mass and muscle strength.

Safety:

MK2866 is considered safe for use in humans, but it is still important to exercise caution when using any performance enhancing drug. It is important to follow the recommended dosage guidelines and monitor for any adverse effects. Some of the potential side effects of MK2866 include acne, hair loss, and changes in cholesterol levels. It is also important to note that MK2866 is a banned substance in many sports organizations and competitions.

Side-Effects:

Some of the potential side effects of MK2866 include acne, hair loss, and changes in cholesterol levels. It is also important to note that MK2866 is a banned substance in many sports organizations and competitions.

Dosage information:

The recommended dosage of MK2866 varies depending on the intended use. For muscle building and performance enhancement, a dosage of 10-20mg per day is typically recommended. However, it is important to start with a lower dosage and gradually increase as needed. It is also important to cycle off of MK2866 after several weeks of use in order to prevent any long-term effects on hormone levels.

In conclusion, MK2866 is a selective androgen receptor modulator that has been studied for its potential benefits in treating muscle wasting and osteoporosis. It has also shown promise as a performance enhancing drug for athletes and bodybuilders. It is important to exercise caution when using MK2866 and to follow the recommended dosage guidelines to avoid any potential side effects. As with any performance enhancing drug, it is also important to research the regulations in your sport or competition to avoid any potential consequences.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code